Review of tolvaptan for autosomal dominant polycystic kidney disease.
about
The Role of G-Protein-Coupled Receptor Proteolysis Site Cleavage of Polycystin-1 in Renal Physiology and Polycystic Kidney DiseaseCurrent management of autosomal dominant polycystic kidney diseaseLack of Benefit of Early Intervention with Dietary Flax and Fish Oil and Soy Protein in Orthologous Rodent Models of Human Hereditary Polycystic Kidney DiseaseHuman polycystin-2 transgene dose-dependently rescues ADPKD phenotypes in Pkd2 mutant mice.Vasopressin receptor antagonists.Combination drug versus monotherapy for the treatment of autosomal dominant polycystic kidney disease.Validation of Effective Therapeutic Targets for ADPKD Using Animal Models.Is the light at the end of the tunnel nigh? A review of ADPKD focusing on the burden of disease and tolvaptan as a new treatment.Cost-effectiveness of angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers as first-line treatment in autosomal dominant polycystic kidney disease.Investigation and comparison of the binding between tolvaptan and pepsin and trypsin: Multi-spectroscopic approaches and molecular docking.
P2860
Q26775090-63FA440C-60DE-4C37-9C91-CE501FE2EC3FQ26784073-83849DB3-C78A-459D-A4A7-0107216347EFQ36026246-ECB84AC6-348A-4192-9462-8B193FFEA326Q36167611-55DCEAA5-9F4D-4E40-B478-49B57DFC4AD6Q38325590-4F5A0F57-2AB9-4D7F-A485-E0E605D888E4Q38960067-320679B8-38E3-478C-9F85-87DCEC811367Q38978468-C9155F02-F7A6-474C-84F2-1B6C1DD93D1AQ50024807-2A0D0FE1-0D43-4B43-9727-18C345551E95Q50780550-CD464303-E18B-492F-9D4E-EE84B35391A3Q51016484-638435B0-8399-4183-B759-09F408C968E0
P2860
Review of tolvaptan for autosomal dominant polycystic kidney disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Review of tolvaptan for autosomal dominant polycystic kidney disease.
@en
type
label
Review of tolvaptan for autosomal dominant polycystic kidney disease.
@en
prefLabel
Review of tolvaptan for autosomal dominant polycystic kidney disease.
@en
P2860
P356
P1433
P1476
Review of tolvaptan for autosomal dominant polycystic kidney disease
@en
P2093
Brian P Baur
P2860
P304
P356
10.1002/PHAR.1421
P407
P577
2014-04-07T00:00:00Z